Predictive value of serum homocysteine and potassium ion for short-term prognosis of patients with acute cerebral infarction following intravenous thrombolysis with recombinant tissue plasminogen activator

Key Result

Serum homocysteine and potassium ion levels are novel biomarkers for predicting short-term prognosis in acute cerebral infarction patients after rt-PA thrombolysis.

Key Points

• This research aims to evaluate the predictive value of serum homocysteine and potassium levels for short-term outcomes in acute cerebral infarction patients post-thrombolysis.
• Analyzed serum levels of homocysteine and potassium in patients
• Monitored short-term prognosis following intravenous thrombolysis with rt-PA
• Used statistical methods to establish correlations between biomarker levels and outcomes
• Higher serum homocysteine levels correlate with poorer short-term prognosis
• Elevated potassium ion levels are associated with increased risk of adverse outcomes
• Both biomarkers are suggested as effective predictors for short-term prognosis in ACI patients